Results of a Randomized Open Multicenter Comparative Study of the Tolerability and Safety of Gilenya (fingolimod) in Patients with Remitting Multiple Sclerosis (the GIMN study)
Crossref DOI link: https://doi.org/10.1007/s11055-016-0370-2
Published Online: 2016-11-19
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Popova, E. V.
,
Boiko, A. N.
Boiko, O. V.
License valid from 2016-11-19